Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
Site Announcement

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

Investors
  • Overview
  • Corporate News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Leadership
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
    • IRS Form 8937 for 2019 Reverse Stock Split
    • IRS Form 8937 for 2023 Reverse Stock Split
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Governance Documents
  • Analyst Coverage

Press Releases

  • Corporate News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jul 29, 2021

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2021

Jun 24, 2021

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

Jun 21, 2021

Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021

Jun 10, 2021

Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jun 3, 2021

Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier®

Mar 1, 2021

Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences

Feb 10, 2021

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

Feb 4, 2021

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 10, 2021

Jan 6, 2021

Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer

Jan 4, 2021

Aethlon Medical to Present at the H.C. Wainwright BioConnect 2021 Conference

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.